US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alto Neuroscience Inc

36.43

+0.18000.50%

Volume:295.01K

Turnover:10.78M

Market Cap:1.42B

PE:-15.30

High:37.43

Open:36.58

Low:35.74

Close:36.25

52wk High:37.43

52wk Low:3.41

Shares:38.87M

Float Shares:28.30M

Volume Ratio:0.84

T/O Rate:1.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3816

EPS(LYR):-2.1918

ROE:-49.17%

ROA:-26.79%

PB:6.46

PE(LYR):-16.62

Loading ...

Overview Company News Filings

Alto Neuroscience announces ALTO-101 did not achieve statistical significance

Alto Neuroscience Shares Down 18.8% at $19.01 in Extended Trade After Schizophrenia Cognition Study Misses Primary Endpoint

THOMSON REUTERS

Alto Neuroscience says Phase 2 ALTO-101 schizophrenia cognition study misses primary endpoint

Alto Neuroscience Inc: Development of Alto-207 Remains Top Priority for Company; Phase 2B on Track to Initiate in 1H 2026

THOMSON REUTERS

Alto Neuroscience Inc: in Proof-of-Concept Study, Alto-101 Did Not Achieve Statistical Significance on Primary Endpoint

THOMSON REUTERS

Alto Neuroscience:Developed Modified-Release, Once-Daily Oral Formulation of Alto-101,Plans to Explore Partnering Opportunities for This Formulation

THOMSON REUTERS

Alto Neuroscience announces virtual annual meeting; record-date shares outstanding total 31.9 million

Alto Neuroscience Inc reports results for the quarter ended December 31 - Earnings Summary

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO), Johnson & Johnson (JNJ) and InspireMD (NSPR)

Alto Neuroscience Inc expected to post a loss of 52 cents a share - Earnings Preview

Alto Neuroscience Is Maintained at Outperform by Baird

U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

Alto Neuroscience Inc : Baird Raises Target Price to $41 From $22

THOMSON REUTERS

Alto Neuroscience: Advancing Late-Stage CNS Pipeline and Strengthened Balance Sheet Support Favorable Risk-Reward Profile

Alto Neuroscience Is Maintained at Neutral by Wedbush

Alto Neuroscience price target raised to $22 from $13 at Wedbush

Alto Neuroscience Inc : Wedbush Raises Target Price to $22 From $13

THOMSON REUTERS

Alto Neuroscience: Advancing Precision-Psychiatry Pipeline and De-Risked Trials Support Buy Rating

Wedbush Raises Alto Neuroscience Price Target to $22 From $13, Maintains Neutral Rating

MT Newswires Live

Alto Neuroscience Inc. releases corporate presentation on its biomarker-driven CNS drug pipeline with five mid-to-late-stage data readouts

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ANRO/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ANRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","market":"US","secType":"STK","nameCN":"Alto Neuroscience Inc","latestPrice":36.43,"timestamp":1787682882213,"preClose":36.25,"halted":0,"volume":295006,"delay":0,"changeRate":0.004965517241379303,"floatShares":28296500,"shares":38870376,"eps":-2.381577,"marketStatus":"Trading","change":0.18,"latestTime":"08-25 14:34:42 EDT","open":36.58,"high":37.43,"low":35.74,"amount":10782484.935317999,"amplitude":0.046621,"askPrice":36.4,"askSize":25,"bidPrice":36.31,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-2.381577,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1706850000000,"exchange":"NYSE","adjPreClose":36.25,"preHourTrading":{"tag":"盘前","latestPrice":37.02,"preClose":36.25,"latestTime":"09:12 EDT","volume":284,"amount":10404.446784,"timestamp":1787663540793,"change":0.77,"changeRate":0.021241,"amplitude":0.026207},"postHourTrading":{"tag":"盘后","latestPrice":36.5,"preClose":36.25,"latestTime":"19:30 EDT","volume":6925,"amount":251486.4535,"timestamp":1787614204847,"change":0.25,"changeRate":0.006897,"amplitude":0.019862},"volumeRatio":0.840991,"impliedVol":0.7816,"impliedVolPercentile":0.3108},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","floatShares":28296500,"roa":"-26.79%","roe":"-49.17%","lyrEps":-2.191806,"volumeRatio":0.840991,"shares":38870376,"dividePrice":0,"high":37.43,"amplitude":0.046621,"preClose":36.25,"low":35.74,"week52Low":3.41,"pbRate":"6.46","week52High":37.43,"institutionHeld":0,"latestPrice":36.43,"committee":0.090909,"eps":-2.381577,"divideRate":0,"volume":295006,"delay":0,"ttmEps":-2.381577,"open":36.58,"prevYearClose":17.8,"prevWeekClose":34.28,"prevMonthClose":27.07,"prevQuarterClose":26.39,"fiveDayClose":34.13,"twentyDayClose":27.42,"sixtyDayClose":20.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"ANRO","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2026-05-13","symbol":"ANRO","fiscalQuarterEnding":"2026/03","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.8},{"market":"US","date":"2026-03-16","symbol":"ANRO","fiscalQuarterEnding":"2025/12","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-11-12","symbol":"ANRO","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-08-13","symbol":"ANRO","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6364,"buy":0.2727,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6364,"analysts":11,"updateTime":1786939200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANRO","date":"2026-08-21","current":-15.221007,"percent":0.003231,"low":-16.978804,"twenty":-10.831771,"median":-6.749002,"eighty":-1.49576,"high":-0.793245,"avg":-6.422904,"sd":4.54375,"marketCap":1344042062},"quantilePoints":[{"date":"2024-02-09","current":-15.481605,"twenty":-16.048587,"median":-15.481605,"eighty":-13.872658,"marketCap":506867732},{"date":"2024-02-16","current":-12.96931,"twenty":-15.548491,"median":-13.234406,"eighty":-11.571235,"marketCap":424615224},{"date":"2024-02-23","current":-10.603839,"twenty":-15.481605,"median":-12.585941,"eighty":-11.026361,"marketCap":347169680},{"date":"2024-03-01","current":-12.56147,"twenty":-14.292343,"median":-12.488059,"eighty":-11.135662,"marketCap":411262544},{"date":"2024-03-08","current":-11.631595,"twenty":-13.230328,"median":-12.361629,"eighty":-11.293904,"marketCap":380818433},{"date":"2024-03-15","current":-12.153631,"twenty":-13.001937,"median":-12.137317,"eighty":-11.306955,"marketCap":397909864},{"date":"2024-03-22","current":-11.14409,"twenty":-12.949734,"median":-12.108768,"eighty":-11.306955,"marketCap":404586204},{"date":"2024-03-28","current":-12.415912,"twenty":-12.956259,"median":-12.145474,"eighty":-11.437463,"marketCap":450759680},{"date":"2024-04-05","current":-10.418119,"twenty":-12.920369,"median":-11.868143,"eighty":-11.162905,"marketCap":378229815},{"date":"2024-04-12","current":-10.440317,"twenty":-12.863272,"median":-11.793418,"eighty":-10.823597,"marketCap":379035702},{"date":"2024-04-19","current":-9.988964,"twenty":-12.713187,"median":-11.631595,"eighty":-10.532067,"marketCap":362649325},{"date":"2024-04-26","current":-10.455115,"twenty":-12.538631,"median":-11.566341,"eighty":-10.461035,"marketCap":379572960},{"date":"2024-05-03","current":-10.654895,"twenty":-12.497847,"median":-11.513206,"eighty":-10.478793,"marketCap":386825947},{"date":"2024-05-10","current":-10.802879,"twenty":-12.4592,"median":-11.360121,"eighty":-10.478793,"marketCap":392198529},{"date":"2024-05-17","current":-8.114957,"twenty":-12.377436,"median":-11.191128,"eighty":-10.431438,"marketCap":344382544},{"date":"2024-05-24","current":-7.443985,"twenty":-12.295701,"median":-11.079356,"eighty":-10.270134,"marketCap":315907856},{"date":"2024-05-31","current":-7.59948,"twenty":-12.254775,"median":-10.943138,"eighty":-9.999323,"marketCap":322506720},{"date":"2024-06-07","current":-7.453823,"twenty":-12.218885,"median":-10.773282,"eighty":-9.088414,"marketCap":316325341},{"date":"2024-06-14","current":-7.612146,"twenty":-12.153631,"median":-10.654895,"eighty":-8.114957,"marketCap":323044231},{"date":"2024-06-21","current":-6.997854,"twenty":-12.14058,"median":-10.580902,"eighty":-7.890353,"marketCap":296974938},{"date":"2024-06-28","current":-6.731872,"twenty":-12.125897,"median":-10.558705,"eighty":-7.854905,"marketCap":285687202},{"date":"2024-07-05","current":-7.35883,"twenty":-12.080219,"median":-10.514309,"eighty":-7.738804,"marketCap":312294007},{"date":"2024-07-12","current":-8.486086,"twenty":-11.912764,"median":-10.492111,"eighty":-7.738804,"marketCap":360132504},{"date":"2024-07-15","current":-8.840728,"twenty":-11.90384,"median":-10.492111,"eighty":-7.738804,"marketCap":375182817},{"date":"2024-08-02","current":-6.212575,"twenty":-11.894916,"median":-10.481012,"eighty":-7.674208,"marketCap":263649243},{"date":"2024-08-09","current":-5.762939,"twenty":-11.86488,"median":-10.440317,"eighty":-7.584281,"marketCap":244567596},{"date":"2024-08-16","current":-5.077305,"twenty":-11.842621,"median":-10.421819,"eighty":-7.439715,"marketCap":252875166},{"date":"2024-08-23","current":-5.770157,"twenty":-11.798049,"median":-10.270134,"eighty":-7.320833,"marketCap":287382652},{"date":"2024-08-30","current":-6.766131,"twenty":-11.747422,"median":-10.066655,"eighty":-7.023186,"marketCap":336987162},{"date":"2024-09-06","current":-6.885215,"twenty":-11.696849,"median":-9.985264,"eighty":-6.997854,"marketCap":342918136},{"date":"2024-09-13","current":-7.036776,"twenty":-11.629964,"median":-9.589405,"eighty":-7.005638,"marketCap":350466649},{"date":"2024-09-20","current":-7.269531,"twenty":-11.615282,"median":-8.800669,"eighty":-7.041657,"marketCap":362059007},{"date":"2024-09-27","current":-6.495486,"twenty":-11.576129,"median":-8.327763,"eighty":-6.997854,"marketCap":323507676},{"date":"2024-10-04","current":-5.51575,"twenty":-11.542663,"median":-8.073812,"eighty":-6.792939,"marketCap":274711934},{"date":"2024-10-11","current":-6.392641,"twenty":-11.505807,"median":-7.947789,"eighty":-6.506312,"marketCap":318385471},{"date":"2024-10-18","current":-7.724215,"twenty":-11.453451,"median":-7.863613,"eighty":-6.586066,"marketCap":384704544},{"date":"2024-10-25","current":-2.23553,"twenty":-11.361501,"median":-7.821648,"eighty":-6.506312,"marketCap":111340558},{"date":"2024-10-31","current":-2.181401,"twenty":-11.357822,"median":-7.776801,"eighty":-6.403467,"marketCap":108644661},{"date":"2024-11-08","current":-2.083968,"twenty":-11.223755,"median":-7.738804,"eighty":-6.212575,"marketCap":103792046},{"date":"2024-11-15","current":-2.159604,"twenty":-11.191128,"median":-7.724215,"eighty":-6.11117,"marketCap":124062772},{"date":"2024-11-22","current":-1.92017,"twenty":-11.14409,"median":-7.634377,"eighty":-5.98126,"marketCap":110307987},{"date":"2024-11-29","current":-2.070403,"twenty":-11.113816,"median":-7.615312,"eighty":-5.768005,"marketCap":118938440},{"date":"2024-12-06","current":-1.830969,"twenty":-11.06322,"median":-7.574148,"eighty":-5.648645,"marketCap":105183655},{"date":"2024-12-13","current":-1.798105,"twenty":-11.000259,"median":-7.504253,"eighty":-5.44863,"marketCap":103295743},{"date":"2024-12-20","current":-1.746462,"twenty":-10.916697,"median":-7.443985,"eighty":-5.07514,"marketCap":100329024},{"date":"2024-12-27","current":-2.075098,"twenty":-10.841355,"median":-7.436869,"eighty":-2.363274,"marketCap":119208142},{"date":"2025-01-03","current":-2.056319,"twenty":-10.79104,"median":-7.390494,"eighty":-2.255016,"marketCap":118129335},{"date":"2025-01-10","current":-2.070403,"twenty":-10.767363,"median":-7.35883,"eighty":-2.165554,"marketCap":118938440},{"date":"2025-01-17","current":-2.079793,"twenty":-10.725927,"median":-7.312287,"eighty":-2.141345,"marketCap":119477844},{"date":"2025-01-24","current":-2.272279,"twenty":-10.654895,"median":-7.277651,"eighty":-2.138097,"marketCap":130535613},{"date":"2025-01-31","current":-2.093877,"twenty":-10.603839,"median":-7.253293,"eighty":-2.122046,"marketCap":120286949},{"date":"2025-02-07","current":-1.854443,"twenty":-10.580902,"median":-7.17813,"eighty":-2.093877,"marketCap":106532163},{"date":"2025-02-14","current":-1.530502,"twenty":-10.558705,"median":-7.145034,"eighty":-2.075098,"marketCap":87922747},{"date":"2025-02-21","current":-1.464775,"twenty":-10.529107,"median":-7.061183,"eighty":-2.070403,"marketCap":84146924},{"date":"2025-02-28","current":-1.305152,"twenty":-10.515789,"median":-6.997854,"eighty":-2.041295,"marketCap":74977067},{"date":"2025-03-07","current":-1.854443,"twenty":-10.50839,"median":-6.933931,"eighty":-2.023455,"marketCap":106532163},{"date":"2025-03-14","current":-1.483554,"twenty":-10.495071,"median":-6.768,"eighty":-2.01289,"marketCap":85225730},{"date":"2025-03-21","current":-1.180996,"twenty":-10.492111,"median":-6.549615,"eighty":-1.993408,"marketCap":72549751},{"date":"2025-03-28","current":-1.062067,"twenty":-10.474353,"median":-6.422411,"eighty":-1.971812,"marketCap":65243830},{"date":"2025-04-04","current":-0.81528,"twenty":-10.458075,"median":-6.392641,"eighty":-1.92017,"marketCap":50083438},{"date":"2025-04-11","current":-0.903418,"twenty":-10.443277,"median":-6.253891,"eighty":-1.873222,"marketCap":55497864},{"date":"2025-04-17","current":-0.991556,"twenty":-10.440317,"median":-6.19297,"eighty":-1.833785,"marketCap":60912290},{"date":"2025-04-25","current":-1.004777,"twenty":-10.431438,"median":-6.11117,"eighty":-1.798105,"marketCap":61724454},{"date":"2025-05-02","current":-1.079695,"twenty":-10.421079,"median":-6.037568,"eighty":-1.742706,"marketCap":66326716},{"date":"2025-05-09","current":-0.965115,"twenty":-10.40924,"median":-5.975847,"eighty":-1.645994,"marketCap":59287962},{"date":"2025-05-16","current":-1.041186,"twenty":-10.323409,"median":-5.766106,"eighty":-1.583083,"marketCap":65785273},{"date":"2025-05-23","current":-1.255422,"twenty":-10.270134,"median":-5.686944,"eighty":-1.500455,"marketCap":79321337},{"date":"2025-05-30","current":-1.152589,"twenty":-10.199102,"median":-5.617282,"eighty":-1.480737,"marketCap":72824027},{"date":"2025-06-06","current":-1.019763,"twenty":-10.071835,"median":-5.469741,"eighty":-1.461958,"marketCap":64431667},{"date":"2025-06-13","current":-1.049756,"twenty":-10.02004,"median":-5.30697,"eighty":-1.408438,"marketCap":66326716},{"date":"2025-06-20","current":-0.972631,"twenty":-9.987484,"median":-5.077305,"eighty":-1.322054,"marketCap":61453732},{"date":"2025-06-27","current":-0.985485,"twenty":-9.980084,"median":-2.492642,"eighty":-1.263991,"marketCap":62265896},{"date":"2025-07-03","current":-1.006909,"twenty":-9.974165,"median":-2.341082,"eighty":-1.221144,"marketCap":63619503},{"date":"2025-07-11","current":-1.105457,"twenty":-9.589405,"median":-2.272279,"eighty":-1.163435,"marketCap":69846092},{"date":"2025-07-18","current":-1.233999,"twenty":-8.963166,"median":-2.213594,"eighty":-1.13545,"marketCap":77967731},{"date":"2025-07-25","current":-1.319693,"twenty":-8.840728,"median":-2.178383,"eighty":-1.148304,"marketCap":83382157},{"date":"2025-08-01","current":-1.315408,"twenty":-8.760609,"median":-2.161951,"eighty":-1.152589,"marketCap":83111436},{"date":"2025-08-08","current":-1.311123,"twenty":-8.486086,"median":-2.154336,"eighty":-1.163435,"marketCap":82840714},{"date":"2025-08-15","current":-1.302504,"twenty":-8.327763,"median":-2.124393,"eighty":-1.163435,"marketCap":84479082},{"date":"2025-08-22","current":-1.498714,"twenty":-8.182106,"median":-2.122046,"eighty":-1.165443,"marketCap":97205098},{"date":"2025-08-29","current":-1.590557,"twenty":-8.114957,"median":-2.098572,"eighty":-1.169728,"marketCap":103161956},{"date":"2025-09-05","current":-1.465317,"twenty":-8.049126,"median":-2.084227,"eighty":-1.178742,"marketCap":95038967},{"date":"2025-09-12","current":-1.640654,"twenty":-7.979964,"median":-2.075098,"eighty":-1.18912,"marketCap":106411151},{"date":"2025-09-19","current":-1.715798,"twenty":-7.951589,"median":-2.070403,"eighty":-1.198007,"marketCap":111284945},{"date":"2025-09-26","current":-1.586383,"twenty":-7.904286,"median":-2.056319,"eighty":-1.216859,"marketCap":102891190},{"date":"2025-10-03","current":-1.841039,"twenty":-7.881184,"median":-2.039887,"eighty":-1.228,"marketCap":119407933},{"date":"2025-10-10","current":-2.513164,"twenty":-7.867586,"median":-2.056319,"eighty":-1.233142,"marketCap":163001306},{"date":"2025-10-17","current":-2.454718,"twenty":-7.85227,"median":-2.070403,"eighty":-1.244282,"marketCap":159210578},{"date":"2025-10-24","current":-4.667305,"twenty":-7.827138,"median":-2.075098,"eighty":-1.253708,"marketCap":302716712},{"date":"2025-10-31","current":-5.978158,"twenty":-7.812987,"median":-2.084227,"eighty":-1.2897,"marketCap":387737327},{"date":"2025-11-07","current":-4.646431,"twenty":-7.783605,"median":-2.103267,"eighty":-1.301657,"marketCap":301362880},{"date":"2025-11-14","current":-4.738274,"twenty":-7.773873,"median":-2.122046,"eighty":-1.304622,"marketCap":307319739},{"date":"2025-11-21","current":-7.060871,"twenty":-7.758215,"median":-2.12674,"eighty":-1.306199,"marketCap":439588640},{"date":"2025-11-28","current":-6.91117,"twenty":-7.745076,"median":-2.154336,"eighty":-1.306688,"marketCap":430268739},{"date":"2025-12-05","current":-6.67664,"twenty":-7.738804,"median":-2.161951,"eighty":-1.306839,"marketCap":415667562},{"date":"2025-12-12","current":-7.325342,"twenty":-7.736546,"median":-2.178383,"eighty":-1.309247,"marketCap":456053797},{"date":"2025-12-19","current":-9.705579,"twenty":-7.761946,"median":-2.213594,"eighty":-1.311015,"marketCap":604240215},{"date":"2025-12-26","current":-9.920149,"twenty":-7.817318,"median":-2.253904,"eighty":-1.311123,"marketCap":617598739},{"date":"2026-01-02","current":-8.882226,"twenty":-7.875492,"median":-2.303191,"eighty":-1.311123,"marketCap":552980763},{"date":"2026-01-09","current":-7.929133,"twenty":-7.944058,"median":-2.354526,"eighty":-1.311807,"marketCap":493644063},{"date":"2026-01-16","current":-8.493005,"twenty":-8.098499,"median":-2.410079,"eighty":-1.314542,"marketCap":528749021},{"date":"2026-01-23","current":-8.572845,"twenty":-8.233524,"median":-2.467243,"eighty":-1.314542,"marketCap":533719635},{"date":"2026-01-30","current":-7.644703,"twenty":-8.248494,"median":-2.550736,"eighty":-1.315408,"marketCap":475936252},{"date":"2026-02-06","current":-7.040911,"twenty":-8.233524,"median":-2.675047,"eighty":-1.315408,"marketCap":438345986},{"date":"2026-02-13","current":-8.203584,"twenty":-8.278435,"median":-4.258185,"eighty":-1.315408,"marketCap":510730547},{"date":"2026-02-20","current":-9.730529,"twenty":-8.329873,"median":-4.59216,"eighty":-1.315408,"marketCap":605793532},{"date":"2026-02-27","current":-9.625739,"twenty":-8.433125,"median":-4.619295,"eighty":-1.315408,"marketCap":599269602},{"date":"2026-03-06","current":-10.26945,"twenty":-8.504981,"median":-4.688178,"eighty":-1.318836,"marketCap":639345174},{"date":"2026-03-13","current":-11.092803,"twenty":-8.596797,"median":-4.780021,"eighty":-1.319693,"marketCap":690604627},{"date":"2026-03-20","current":-10.997993,"twenty":-8.80207,"median":-5.077305,"eighty":-1.323121,"marketCap":684702023},{"date":"2026-03-27","current":-10.5175,"twenty":-8.978914,"median":-5.159821,"eighty":-1.327405,"marketCap":665105643},{"date":"2026-04-02","current":-11.825873,"twenty":-9.157675,"median":-5.286907,"eighty":-1.342565,"marketCap":747844529},{"date":"2026-04-10","current":-11.315658,"twenty":-9.59795,"median":-5.418318,"eighty":-1.358364,"marketCap":715579558},{"date":"2026-04-17","current":-14.44502,"twenty":-9.715559,"median":-5.499511,"eighty":-1.373177,"marketCap":913474169},{"date":"2026-04-24","current":-14.251015,"twenty":-9.940109,"median":-5.617282,"eighty":-1.380269,"marketCap":901205714},{"date":"2026-05-01","current":-14.2233,"twenty":-9.993374,"median":-5.686437,"eighty":-1.40625,"marketCap":899453077},{"date":"2026-05-08","current":-13.341966,"twenty":-10.092797,"median":-5.762939,"eighty":-1.428579,"marketCap":843719235},{"date":"2026-05-15","current":-11.128225,"twenty":-10.269724,"median":-5.815711,"eighty":-1.431919,"marketCap":826893924},{"date":"2026-05-22","current":-10.161169,"twenty":-10.270134,"median":-5.928061,"eighty":-1.443182,"marketCap":755035825},{"date":"2026-05-29","current":-9.538479,"twenty":-10.26986,"median":-5.978158,"eighty":-1.454447,"marketCap":708766220},{"date":"2026-06-05","current":-9.448849,"twenty":-10.241369,"median":-6.015388,"eighty":-1.46008,"marketCap":702106201},{"date":"2026-06-12","current":-10.121163,"twenty":-10.184016,"median":-6.089518,"eighty":-1.46008,"marketCap":752063134},{"date":"2026-06-18","current":-10.291187,"twenty":-10.191631,"median":-6.176125,"eighty":-1.461019,"marketCap":764696952},{"date":"2026-06-26","current":-11.948923,"twenty":-10.281083,"median":-6.203076,"eighty":-1.464883,"marketCap":887876682},{"date":"2026-07-02","current":-11.778899,"twenty":-10.355847,"median":-6.327685,"eighty":-1.465317,"marketCap":875242863},{"date":"2026-07-10","current":-13.05408,"twenty":-10.419151,"median":-6.392641,"eighty":-1.474164,"marketCap":969996501},{"date":"2026-07-17","current":-14.296657,"twenty":-10.441725,"median":-6.422411,"eighty":-1.474164,"marketCap":1062327376},{"date":"2026-07-24","current":-14.045563,"twenty":-10.492111,"median":-6.506979,"eighty":-1.478859,"marketCap":1043669595},{"date":"2026-07-31","current":-14.976703,"twenty":-10.518342,"median":-6.61177,"eighty":-1.482615,"marketCap":1112858864},{"date":"2026-08-07","current":-14.893005,"twenty":-10.61405,"median":-6.65169,"eighty":-1.485663,"marketCap":1106639604},{"date":"2026-08-14","current":-15.04689,"twenty":-10.749604,"median":-6.68163,"eighty":-1.487837,"marketCap":1267519959},{"date":"2026-08-21","current":-15.955294,"twenty":-10.831771,"median":-6.749002,"eighty":-1.49576,"marketCap":1344042062}],"updateTime":1787642040264},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANRO\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624541473","title":"Alto Neuroscience announces ALTO-101 did not achieve statistical significance","url":"https://stock-news.laohu8.com/highlight/detail?id=2624541473","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624541473?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:36","pubTimestamp":1775075774,"startTime":"0","endTime":"0","summary":"Alto Neuroscience (ANRO) announced topline data from its Phase 2 proof-of-concept clinical trial evaluating ALTO-101 for the treatment of cognitive...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-announces-alto-101-did-not-achieve-statistical-significance-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-announces-alto-101-did-not-achieve-statistical-significance-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALTO","ANRO","BK4007","BK4138","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624619541","title":"Alto Neuroscience Shares Down 18.8% at $19.01 in Extended Trade After Schizophrenia Cognition Study Misses Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2624619541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624619541?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:34","pubTimestamp":1775075668,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nL6N40K1C7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624541537","title":"Alto Neuroscience says Phase 2 ALTO-101 schizophrenia cognition study misses primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2624541537","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624541537?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:30","pubTimestamp":1775075450,"startTime":"0","endTime":"0","summary":"Alto Neuroscience reported topline Phase 2 proof-of-concept results for ALTO-101 in cognitive impairment associated with schizophrenia.Study failed to meet primary endpoints versus placebo, limiting near-term path to independent development in this indication.More detailed results will be presented at a future medical conference.Strategy shifts toward seeking partners for a once-daily modified-release oral ALTO-101 formulation developed to improve tolerability.Pipeline focus moves to lead program ALTO-207, with Phase 2b initiation targeted for 1H 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL6C96bJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624415855","title":"Alto Neuroscience Inc: Development of Alto-207 Remains Top Priority for Company; Phase 2B on Track to Initiate in 1H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2624415855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624415855?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:30","pubTimestamp":1775075412,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K14F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624415335","title":"Alto Neuroscience Inc: in Proof-of-Concept Study, Alto-101 Did Not Achieve Statistical Significance on Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2624415335","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624415335?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:30","pubTimestamp":1775075412,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K14F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624415235","title":"Alto Neuroscience:Developed Modified-Release, Once-Daily Oral Formulation of Alto-101,Plans to Explore Partnering Opportunities for This Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2624415235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624415235?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:30","pubTimestamp":1775075412,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K14F:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622389648","title":"Alto Neuroscience announces virtual annual meeting; record-date shares outstanding total 31.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622389648","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622389648?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:07","pubTimestamp":1774555676,"startTime":"0","endTime":"0","summary":"Alto Neuroscience will hold its annual stockholder meeting via virtual webcast on May 12, 2026.Voting items include electing Raymond Sanchez and Gwill York as Class II directors with terms running to the 2029 annual meeting.Stockholders will also vote on ratifying Deloitte as Alto’s independent registered public accounting firm.Another proposal seeks approval to amend and restate the 2024 Equity Incentive Plan to treat outstanding pre-funded warrants like common shares for calculating automatic share reserve increases.A separate proposal seeks approval to amend and restate the 2024 Employee Stock Purchase Plan on the same pre-funded warrant treatment for automatic share reserve increases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL7hkwZ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621754416","title":"Alto Neuroscience Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2621754416","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621754416?lang=en_us&edition=fundamental","pubTime":"2026-03-21 05:01","pubTimestamp":1774040467,"startTime":"0","endTime":"0","summary":"Alto Neuroscience Inc reports results for the quarter ended December 31 - Earnings SummaryAlto Neuroscience Inc ANRO.N reported a quarterly adjusted loss of 58 cents per share for the quarter ended De","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N4082D7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620225504","title":"Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO), Johnson & Johnson (JNJ) and InspireMD (NSPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225504","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620225504?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:10","pubTimestamp":1773925810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alto Neuroscience, Inc. (ANRO), Johnson & Johnson (J...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-johnson-johnson-jnj-and-inspiremd-nspr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-johnson-johnson-jnj-and-inspiremd-nspr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1059921491.USD","BK4588","LU0114720955.EUR","LU0345770993.USD","SG9999002224.SGD","XBI","LU1023059063.AUD","LU0128526141.USD","LU1674673691.USD","LU1066051498.USD","LU1244550221.USD","IE0001KFT4U8.USD","NSPR","IE00BVYPNV92.GBP","LU0882574055.USD","BK4198","LABU","JNJ","IE000M9KFDE8.USD","LU1732799900.SGD","LU1674673428.USD","LU0070217475.USD","LU0234570918.USD","LU1066051811.HKD","LU0203347892.USD","LU1221951046.USD","LU1267930813.SGD","LU1280957306.USD","IE00BSNM7G36.USD","XLV","LU2129689514.USD","IE00BBT3K403.USD","LU2505996509.AUD","IE00BFTCPJ56.SGD","HCSG","LU1894683264.USD","ANRO","LU2471134952.CNY","LU1221951129.SGD","LU0683600562.USD","BK4534","LU1983299246.USD","IE00B2B36J28.USD","BK4559","IE00BJT1NW94.SGD","BK4581","LU0345770308.USD","LU1496350502.SGD","LU1061106388.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620264418","title":"Alto Neuroscience Inc  expected to post a loss of 52 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264418","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264418?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:02","pubTimestamp":1773864148,"startTime":"0","endTime":"0","summary":"Alto Neuroscience Inc  expected to post a loss of52cents a share - Earnings Preview Alto Neuroscience Inc ANRO.N, ANRO.K is expected to  show no change in quarterly revenue when it reports  results  f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL8N4062HG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620259374","title":"Alto Neuroscience Is Maintained at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2620259374","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620259374?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:09","pubTimestamp":1773839340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2026 09:09 ET (13:09 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620238304","title":"U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks","url":"https://stock-news.laohu8.com/highlight/detail?id=2620238304","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620238304?lang=en_us&edition=fundamental","pubTime":"2026-03-18 15:36","pubTimestamp":1773819417,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Factset, Lensar, StarbucksMarch 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Wednesday, including Fa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL8N4060HY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","GLXY","ANRO","ECL","ETR","GEMG","ASO","BKKT","HQY","DOW","AJG","FDS","EVMN","GLGG","LU1923621640.USD","FICO","CE","COHR","DOCU","CTMX","BTGO","DUOL","DTE","XYZY","GHM","EQIX","BL","CLYM","CCL","DLR","IE00BMG7P926.USD","XYZ","BTSG","COHX","APD","ANDG","APGE","ARCT","GLXU","LU1992135472.HKD","XYZG","CF","CADL","CALM","LU2360107671.USD","STZ","CRC","CLH","GEMI","DC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620289773","title":"Alto Neuroscience Inc : Baird Raises Target Price to $41 From $22","url":"https://stock-news.laohu8.com/highlight/detail?id=2620289773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620289773?lang=en_us&edition=fundamental","pubTime":"2026-03-18 13:08","pubTimestamp":1773810533,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN4060CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620079477","title":"Alto Neuroscience: Advancing Late-Stage CNS Pipeline and Strengthened Balance Sheet Support Favorable Risk-Reward Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2620079477","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620079477?lang=en_us&edition=fundamental","pubTime":"2026-03-18 03:05","pubTimestamp":1773774315,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral has maintained their bullish stance on ANRO stock, giving a Buy rating today. Ritu Baral has given his Buy rating due t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/alto-neuroscience-advancing-late-stage-cns-pipeline-and-strengthened-balance-sheet-support-favorable-risk-reward-profile-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/alto-neuroscience-advancing-late-stage-cns-pipeline-and-strengthened-balance-sheet-support-favorable-risk-reward-profile-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SSI","BK4135","CNS","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620422560","title":"Alto Neuroscience Is Maintained at Neutral by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2620422560","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620422560?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:36","pubTimestamp":1773750960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 17, 2026 08:36 ET (12:36 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620421292","title":"Alto Neuroscience price target raised to $22 from $13 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2620421292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620421292?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:55","pubTimestamp":1773748523,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico raised the firm’s price target on Alto Neuroscience (ANRO) to $22 from $13 and keeps a Neutral rating on the shares. Mo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-price-target-raised-to-22-from-13-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-price-target-raised-to-22-from-13-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620429882","title":"Alto Neuroscience Inc : Wedbush Raises Target Price to $22 From $13","url":"https://stock-news.laohu8.com/highlight/detail?id=2620429882","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620429882?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:15","pubTimestamp":1773746123,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nFWN4050BQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620428790","title":"Alto Neuroscience: Advancing Precision-Psychiatry Pipeline and De-Risked Trials Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2620428790","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620428790?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:55","pubTimestamp":1773741326,"startTime":"0","endTime":"0","summary":"Analyst Thomas Shrader from BTIG maintained a Buy rating on Alto Neuroscience, Inc. and keeping the price target at $28.00. Thomas Shrader has give...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/alto-neuroscience-advancing-precision-psychiatry-pipeline-and-de-risked-trials-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/alto-neuroscience-advancing-precision-psychiatry-pipeline-and-de-risked-trials-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620956744","title":"Wedbush Raises Alto Neuroscience Price Target to $22 From $13, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2620956744","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620956744?lang=en_us&edition=fundamental","pubTime":"2026-03-17 02:58","pubTimestamp":1773687498,"startTime":"0","endTime":"0","summary":"Price: 24.94, Change: +2.68, Percent Change: +12.02","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619527844","title":"Alto Neuroscience Inc. releases corporate presentation on its biomarker-driven CNS drug pipeline with five mid-to-late-stage data readouts","url":"https://stock-news.laohu8.com/highlight/detail?id=2619527844","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619527844?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:06","pubTimestamp":1773659189,"startTime":"0","endTime":"0","summary":"Alto Neuroscience Inc. releases corporate presentation on its biomarker-driven CNS drug pipeline with five mid-to-late-stage data readouts. Alto Neuroscience outlined its precision medicine strategy for psychiatric and neurological disorders, using biomarker-based patient identification to guide development. The company said more than 600 patients have been dosed across studies of its product candidates and precision approach. Alto listed multiple clinical programs with upcoming data readouts, including ALTO-300 in major depressive disorder with topline data expected mid-2026 and ALTO-100 in bipolar depression with topline data expected in 2H 2026. For ALTO-207 in treatment-resistant depression, Alto plans to initiate a Phase 2b study in 1H 2026 with topline results expected in 2H 2027. The presentation cited a peer-reviewed study link: .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL9wFrYt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":110,"code":"91000000","status":"200"}]}}